Category: 6. Health
-
Scientists watch humans’ most active “parasite gene” cutting DNA
Scientists have finally documented a notorious DNA hitchhiker at work in human cells. The team shows how a protein called ORF2p slices DNA at small openings that form during DNA replication.
During this process, a cell makes an identical copy of…
Continue Reading
-
Congo’s Last Ebola Patient Discharged as Outbreak Nears End
Democratic Republic of Congo discharged its last Ebola patient on Sunday, starting a 42-day countdown to pronouncing the end of the central African nation’s most recent outbreak of the infectious disease.
No new Ebola cases have been reported…
Continue Reading
-
7 Health Benefits Of Coconut Water On Empty Stomach
7 Health Benefits Of Coconut Water On Empty Stomach Image credit: Unsplash
19 October 2025
Nariyal pani, or coconut water, is a refreshing and nutritious beverage that offers several…
Continue Reading
-
ESMO 2025: Overall Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer – UroToday
- ESMO 2025: Overall Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer UroToday
- Drug combo cuts risk of death in advanced prostate cancer by 40%, clinical trial finds Medical Xpress
- Pfizer Co & Astellas announce final overall…
Continue Reading
-
WHO says DRC could declare end of Ebola outbreak by December-Xinhua
KINSHASA, Oct. 19 (Xinhua) — The World Health Organization (WHO) said Sunday that health authorities could declare the end of the current Ebola outbreak in the Democratic Republic of the Congo (DRC) in early December if no new cases are…
Continue Reading
-
ESMO: Vivace tunes up for phase 3 after midstage mesothelioma trial hits high note – Fierce Biotech
- ESMO: Vivace tunes up for phase 3 after midstage mesothelioma trial hits high note Fierce Biotech
- ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma MD Anderson Cancer Center
- YAP/TEAD inhibitor…
Continue Reading
-
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial – Nature
- YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial Nature
- ESMO: Vivace tunes up for phase 3 after midstage mesothelioma trial hits high note Fierce Biotech
- ESMO25: Vivace preps Phase III move for Hippo-targeting mesothelioma drug
Continue Reading
